What are the benefits and risks of GLP-1 drugs beyond weight loss?
BATON ROUGE, La. (WAFB/Gray News) — Doctors have used GLP-1 drugs for weight loss for about five years,…
Generic semaglutide could reshape diabetes drug coverage in Canada | Newsroom
The arrival of generic semaglutide in Canada significantly improves the cost-effectiveness and affordability of recommended treatments for up…
The GLP-1 Pill Era Is Forcing Beauty to Change Again
Beauty gets more intimate The final frontier is one largely absent from early GLP-1 beauty conversations: sexual wellness.…
Tavneos: Rare disease drug recalled in Republic of Ireland
A drug used to treat rare autoimmune diseases has been recalled from shelves in the Republic of Ireland.…
New ‘smart cancer drug’ designed to ‘switch on’ may replace chemotherapy, says govt
In a major breakthrough for cancer treatment in India, the government on Thursday announced a “smart” cancer drug…
California Chiropractor Sentenced to 6 Years in Prison for Misconduct Against Patients
A California chiropractor who claimed his treatments could relieve pain and boost athletic performance is now facing prison…
Lip plumpers, collagen and more: How is Ozempic boosting a new beauty market
Weight-loss drugs such as Ozempic are changing more than just consumers’ waistlines, also reshaping the beauty industry. As…
Ozempic (Semaglutide): Side Effects, Risks & FDA Warnings
What Is Ozempic? Ozempic (semaglutide) is a prescription medicine for treating Type 2 diabetes in adults. It’s also…
Antihistamines may not offer meaningful relief from eczema symptoms
Nearly half of people living with atopic dermatitis (eczema) in the United States turn to oral…
Panadol Osteo and substitute drug hit by national shortage forcing user to ration pain medication
An Auckland retiree says he is rationing the pain medication he relies on to stay active as pharmacies…
Your ideas about antibiotics are probably outdated
Share this Article You are free to share this article under the Attribution 4.0 International license. “Always finish…
Campaigners make final appeal to HSE over Skyclarys drug
Campaigners advocating for those affected by Friedreich’s Ataxia have again appealed to the Health Service Executive (HSE) to…